581 related articles for article (PubMed ID: 26496891)
1. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.
Black PA; de Vos M; Louw GE; van der Merwe RG; Dippenaar A; Streicher EM; Abdallah AM; Sampson SL; Victor TC; Dolby T; Simpson JA; van Helden PD; Warren RM; Pain A
BMC Genomics; 2015 Oct; 16():857. PubMed ID: 26496891
[TBL] [Abstract][Full Text] [Related]
2. A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture.
Bergval I; Coll F; Schuitema A; de Ronde H; Mallard K; Pain A; McNerney R; Clark TG; Anthony RM
FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670707
[TBL] [Abstract][Full Text] [Related]
3. Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background.
Saunders NJ; Trivedi UH; Thomson ML; Doig C; Laurenson IF; Blaxter ML
J Infect; 2011 Mar; 62(3):212-7. PubMed ID: 21237201
[TBL] [Abstract][Full Text] [Related]
4. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.
Trauner A; Liu Q; Via LE; Liu X; Ruan X; Liang L; Shi H; Chen Y; Wang Z; Liang R; Zhang W; Wei W; Gao J; Sun G; Brites D; England K; Zhang G; Gagneux S; Barry CE; Gao Q
Genome Biol; 2017 Apr; 18(1):71. PubMed ID: 28424085
[TBL] [Abstract][Full Text] [Related]
5. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.
Victor TC; Warren R; Butt JL; Jordaan AM; Felix JV; Venter A; Sirgel FA; Schaaf HS; Donald PR; Richardson M; Cynamon MH; Van Helden PD
J Med Microbiol; 1997 Oct; 46(10):847-57. PubMed ID: 9364141
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Within-Host Microevolution of
Ley SD; de Vos M; Van Rie A; Warren RM
Microbiol Mol Biol Rev; 2019 May; 83(2):. PubMed ID: 30918049
[TBL] [Abstract][Full Text] [Related]
7. Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.
Casali N; Broda A; Harris SR; Parkhill J; Brown T; Drobniewski F
PLoS Med; 2016 Oct; 13(10):e1002137. PubMed ID: 27701423
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing for comparative genomics and de novo genome assembly.
Benjak A; Sala C; Hartkoorn RC
Methods Mol Biol; 2015; 1285():1-16. PubMed ID: 25779307
[TBL] [Abstract][Full Text] [Related]
9. Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.
Muzondiwa D; Mutshembele A; Pierneef RE; Reva ON
Int J Med Microbiol; 2020 Feb; 310(2):151399. PubMed ID: 31980371
[TBL] [Abstract][Full Text] [Related]
10. Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant
Ilin AI; Kulmanov ME; Korotetskiy IS; Islamov RA; Akhmetova GK; Lankina MV; Reva ON
Front Cell Infect Microbiol; 2017; 7():151. PubMed ID: 28534009
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates.
Liu F; Hu Y; Wang Q; Li HM; Gao GF; Liu CH; Zhu B
BMC Genomics; 2014 Jun; 15(1):469. PubMed ID: 24923884
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh.
Jain A; Mondal R; Prasad R; Singh K; Ahuja RC
Indian J Med Res; 2008 Sep; 128(3):300-6. PubMed ID: 19052342
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea.
Yoon JH; Nam JS; Kim KJ; Choi Y; Lee H; Cho SN; Ro YT
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):52-61. PubMed ID: 22078903
[TBL] [Abstract][Full Text] [Related]
14. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
17. Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.
Martinez E; Holmes N; Jelfs P; Sintchenko V
J Antimicrob Chemother; 2015 Sep; 70(9):2511-4. PubMed ID: 25977398
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing of Mycobacterium tuberculosis.
Mokrousov I; Chernyaeva E; Vyazovaya A; Sinkov V; Zhuravlev V; Narvskaya O
Emerg Infect Dis; 2016 Jun; 22(6):1127-9. PubMed ID: 27191040
[No Abstract] [Full Text] [Related]
19. Genomic signatures of pre-resistance in Mycobacterium tuberculosis.
Torres Ortiz A; Coronel J; Vidal JR; Bonilla C; Moore DAJ; Gilman RH; Balloux F; Kon OM; Didelot X; Grandjean L
Nat Commun; 2021 Dec; 12(1):7312. PubMed ID: 34911948
[TBL] [Abstract][Full Text] [Related]
20. TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing.
Sekizuka T; Yamashita A; Murase Y; Iwamoto T; Mitarai S; Kato S; Kuroda M
PLoS One; 2015; 10(11):e0142951. PubMed ID: 26565975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
